A Virta Health paper, yet to be released, shows a safe off-ramp may be possible, as hemoglobin A1c and body weight measured 12 months after de-prescription did not significantly differ between patients that continued GLP-1 usage and those that did not
Targeted therapy may help these patients
Collectively, evidence for MGBA involvement in PTSD is consistent across human and preclinical studies, with strong mechanistic convergence, while interventional findings, despite early promise, remain preliminary and require validation in larger, controlled trials
None of these are acceptable
Some doctors do prescribe Mounjaro "off-label" for weight loss, meaning they prescribe it for a purpose other than its official approval